Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-31

FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

FDA approved a supplemental application for simvastatin from NorthStar Rx LLC, updating the approved generic product's labeling/manufacturing information.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

SUPPL AP for SIMVASTATIN (SIMVASTATIN)